Other Clinical Trial - Osteopathic Manipulative Treatment for

See also
Status	Clinical Trial	Phase
Completed	`NCT00384592` - PPI Sequencing Study	Phase 4
Completed	`NCT03793556` - Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor	N/A
Completed	`NCT01507298` - Physical Activity and Gastrointestinal Investigations

See also

Status

Clinical Trial

Phase

Completed

NCT00384592 - PPI Sequencing Study

Phase 4

Completed

NCT03793556 - Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

N/A

Completed

NCT01507298 - Physical Activity and Gastrointestinal Investigations

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06317675
Study type	Interventional
Source	Studio Osteopatico Busto Arsizio
Contact	Carolina Lavazza
Phone	+39 02 96701013
Email	carolina.lavazza@docenti.aimoedu.it
Status	Recruiting
Phase	Phase 2
Start date	February 18, 2024
Completion date	April 2026

Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms